NTRA - Latest News

Natera, Inc. (NTRA), operates in Healthcare / Medical - Diagnostics & Research, trades on NASDAQ.

Market capitalization stands near $46.27B. Beta to the broader market is 1.53.

The article list below shows the most recent NTRA headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent NTRA Headlines

Natera CFO Maps Multiple Paths to $6 Billion Revenue Target by 2029

marketbeat.com - Nov 15, 2026

Natera NASDAQ: NTRA Chief Financial Officer Mike Brophy said the company has multiple paths to its $6 billion revenue target for 2029, citing growth i

Natera CFO Defends CEO Switch, Calls $6 Billion Revenue Target a “Way Station”

marketbeat.com - Nov 14, 2026

Natera NASDAQ: NTRA CFO Mike Brophy said the company's newly announced $6 billion revenue target for 2029 is achievable with strong execution, as he o

Natera, Inc. (NTRA) Presents at 2026 UBS Global Healthcare Conference Transcript

seekingalpha.com - Nov 11, 2026

Natera, Inc. ( NTRA ) 2026 UBS Global Healthcare Conference November 9, 2026 8:00 AM EST Company Participants Mike Brophy - Chief Financial Officer C

Natera, Inc. (NTRA) Presents at 8th Annual Wolfe Research Healthcare Conference Transcript

seekingalpha.com - Nov 11, 2026

Natera, Inc. ( NTRA ) 8th Annual Wolfe Research Healthcare Conference November 10, 2026 12:00 PM EST Company Participants Mike Brophy - Chief Financi

Natera Announces Clinical Collaboration with Incyte on Interventional Phase II Study in Colorectal Cancer

businesswire.com - Nov 10, 2026

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (Nasdaq:NTRA), a global leader in cell-free DNA and precision medicine, today announced that it has ente

How News Affects NTRA Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track NTRA's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked NTRA news questions

What is the latest NTRA news headline?
The most recent NTRA headline (Nov 15, 2026) is "Natera CFO Maps Multiple Paths to $6 Billion Revenue Target by 2029". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the NTRA news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What NTRA news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual NTRA options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.